Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling

Ophthalmologica

Volumn 229, Issue 3, 2013, Pages 142-146

  Yamada, Yoshihisa ^a   Suzuma, Kiyoshi ^a   Kumagami, Takeshi ^a   Fujikawa, Azusa ^a   Kitaoka, Takashi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Diabetic macular edema; Foveal average retinal thickness; Glycosylated hemoglobin; Vitrectomy

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; BODY MASS; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; EPIRETINAL MEMBRANE; FEMALE; HUMAN; INTERNAL LIMITING MEMBRANE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PARS PLANA VITRECTOMY; PROGNOSIS; RETINA MACULA CYSTOID EDEMA; RETINAL THICKNESS; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; VISUAL ACUITY; VITRECTOMY;

EID: 84876499166     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000345494     Document Type: Article

References (28)

1. Porta M, Bandello F: Diabetic retinopathy: A clinical update. Diabetologia 2002; 45: 1617-1634.
2. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report No 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103: 1796-1806.
3. Scott IU, Danis RP, Bressler SB, Bressler NM, Browning DJ, Qin H: Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. Retina 2009; 29: 613-617.
4. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, Lavaque AJ, Larson RJ: Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: A systematic review. Ophthalmology 2009; 116: 902-911, quiz 912.
5. Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR: A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007; 114: 1860-1867.
6. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
7. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) group. Lancet 1998; 352: 837-853.
8. Chase HP, Garg SK, Jackson WE, Thomas MA, Harris S, Marshall G, Crews MJ: Blood pressure and retinopathy in type I diabetes. Ophthalmology 1990; 97: 155-159.
9. Wang Y, Wahba G, Gu C, Klein R, Klein B: Using smoothing spline Anova to examine the relation of risk factors to the incidence and progression of diabetic retinopathy. Stat Med 1997; 16: 1357-1376.
10. Berman DH, Friedman EA: Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin. Retina 1994; 14: 1-5.
11. Sinclair SH, Del Vecchio C, Levin A: Treatment of anemia in the diabetic patient with retinopathy and kidney disease. Am J Ophthalmol 2003; 135: 740-743.
12. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE: The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009; 116: 497-503.
13. Lopes De Faria JM, Jalkh AE, Trempe CL, McMeel JW: Diabetic macular edema: Risk factors and concomitants. Acta Ophthalmol Scand 1999; 77: 170-175.
14. Cusick M, Chew EY, Chan CC, Kruth HS, Murphy RP, Ferris FL 3rd: Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology 2003; 110: 2126-2133.
15. Qiao Q, Keinanen-Kiukaanniemi S, Laara E: The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol 1997; 50: 153-158.
16. Girach A, Lund-Andersen H: Diabetic macular oedema: A clinical overview. Int J Clin Pract 2007; 61: 88-97.
17. Kimura T, Kiryu J, Nishiwaki H, Oh H, Suzuma K, Watanabe D, Kurimoto M, Takagi H: Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 2005; 25: 454-461.
18. Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y: Vitrectomy for diabetic macular edema: Effect of glycemic control (HbA 1c ), renal function (creatinine) and other local factors. Ophthalmic Res 2003; 35: 192-198.
19. Terasaki H, Kojima T, Niwa H, Piao CH, Ueno S, Kondo M, Ito Y, Miyake Y: Changes in focal macular electroretinograms and foveal thickness after vitrectomy for diabetic macular edema. Invest Ophthalmol Vis Sci 2003; 44: 4465-4472.
20. Yamamoto T, Hitani K, Sato Y, Yamashita H, Takeuchi S: Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Ophthalmologica 2005; 219: 206-213.
21. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ: Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 2006; 26: 5-13.
22. Yanyali A, Horozoglu F, Celik E, Nohutcu AF: Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 2007; 27: 557-566.
23. Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG: Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina 2008; 28: 410-419.
24. Hatano N, Mizota A, Tanaka M: Vitreous surgery for diabetic macular edema-its prognosis and correlation between preoperative systemic and ocular conditions and visual outcome. Ann Ophthalmol (Skokie) 2007; 39: 222-227.
25. Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N: Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina 2009; 29: 464-472.
26. Otani T, Kishi S, Maruyama Y: Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999; 127: 688-693.
27. Sakamoto A, Nishijima K, Kita M, Oh H, Tsujikawa A, Yoshimura N: Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1325-1330.
28. Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, Fong DS, Bressler NM, Danis RP, Kinyoun JL, Nguyen QD, Bhavsar AR, Gottlieb J, Pieramici DJ, Rauser ME, Apte RS, Lim JI, Miskala PH: Relationship between optical coherence tomographymeasured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007; 114: 525-536.